Actively Recruiting
Early DiAgnosis Real-Time Healthcare System for CANcer Trial
Led by University College, London · Updated on 2024-12-16
420
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to assess whether the AI characterisation system of the CADDIE device improves the endoscopists accuracy in the optical diagnosis of diminutive colorectal polyps in the bowel during colonoscopy. Participants will either have a colonoscopy with the assistance of the CADDIE device characterisation AI system ("intervention group") or have a colonoscopy in line with routine clinical practice i.e., without the CADDIE device characterisation AI system ("control group"). The randomisation method of this trial will allocate enrolled participants to the "intervention" group and to the "control" group by a technique similar to flipping a coin.
CONDITIONS
Official Title
Early DiAgnosis Real-Time Healthcare System for CANcer Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants scheduled to undergo a screening, surveillance or symptomatic colonoscopy with an endoscopist participating in the study phase of the trial.
- Male and female participants aged 18 years or older at the time of informed consent.
- Participants able to comprehend, sign and date the written informed consent document to participate in the study.
You will not qualify if you...
- Emergency and/or inpatient colonoscopies.
- Participants with inflammatory bowel disease (IBD).
- Participants with current Colorectal Cancer (CRC).
- Participants with a contraindication for biopsy or polypectomy including those who have not withheld medications predisposing to bleeding as per guidelines.
- Participants with a history of bleeding disorders such as haemophilia, clotting factor deficiencies, cirrhosis with coagulopathy, thrombocytopenia (<80,000 platelet/ul), Von Willebrand's disease or platelet malfunction disorders.
- Participants enrolled in another research study with investigational products that increase bleeding risk.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University College London Hospitals NHS Foundation Trust
London, United Kingdom, NW1 2PG
Actively Recruiting
Research Team
S
Sharon Cheung, MSc
CONTACT
R
Rawen Kader, MBBS MRCP
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here